In addition, the percentages of CD14+CD169+ circulating monocytes and TIMs were associated positively with the pathogenic stages of CRC and correlated with the levels of plasma IL-10 and CEA in CRC patients. This evidence concerns the gene SIGLEC1 and colorectal carcinoma.